Background-Immunoglobulin M (IgM) natural antibodies bind oxidatively-modified low-density lipoprotein (LDL) and apoptotic cells and have been implicated as being important for protection against atherosclerosis. We have directly investigated the requirement for IgM by studying the effects of IgM deficiency in LDL receptor-deficient (Ldlr Ϫ/Ϫ ) mice.
O xidative modifications of low-density lipoprotein (LDL) induce inflammatory responses that are key initial steps in the pathogenesis of atherosclerosis. 1 Both innate and adaptive immune responses are thought to contribute to lesion development, with involvement of antibodies that recognize epitopes on oxidized LDL (oxLDL) among other targets. 2 Both immunoglobulin G (IgG) and IgM autoantibodies to oxLDL can be readily detected in both humans and animal models of atherosclerosis, and in some studies, antibody titers correlated with disease severity. [3] [4] [5] IgM monoclonal antibodies reacting with oxLDL have been cloned from apolipoprotein E-deficient (ApoE Ϫ/Ϫ ) mice, and some have been found to bind the phosphorylcholine head group of oxidatively modified phospholipids. 6 -8 The prototypic and best characterized of these, EO6, is identical in sequence to T15, a classical natural antibody known to recognize phosphorylcholine expressed as a capsular epitope on Streptococcus pneumoniae. 8 
Clinical Perspective on p 426
Although initial studies focused on the detrimental effects of antibodies in atherosclerosis, evidence has accumulated suggesting that they also may have protective roles. 9 Numerous studies have shown that immunization with malondialdehyde-modified LDL (MDA-LDL) reduces atherosclerosis and is associated with robust T-cell-dependent IgG anti-oxLDL responses. 10 -12 Immunization of LDL receptor-deficient (Ldlr Ϫ/Ϫ ) or ApoE Ϫ/Ϫ mice with S pneumoniae or phosphorylcholine-conjugated keyhole limpet hemocyanin is also atheroprotective, in association with a rise in IgM anti-phosphorylcholine antibody titer. 13, 14 However, the precise roles of antibodies in active immunization experiments are difficult to interpret conclusively in view of the greater antibody titers achieved by active immunization compared with those obtained spontaneously, 15 as well as the use of adjuvants and the effects of immunization on other immunological parameters such as regulatory T cells. 16 One mechanism by which IgM antibodies may contribute to protection against atherosclerosis is by facilitating the clearance of apoptotic material from developing lesions. Opsonization of apoptotic cells with IgM is known to accelerate their noninflammatory clearance by macrophages, and this process requires cooperation with complement C1q. 17 We have recently shown that C1q deficiency in C1qa.Ldlr Ϫ/Ϫ mice accelerates atherosclerosis. 18 Increased numbers of apoptotic cells were observed in atherosclerotic lesions, consistent with the concept that defective waste disposal leads to accumulation of cellular debris within plaques. 19 -21 In the present study, we sought to examine directly the contribution of IgM antibodies in atherogenesis by crossing Ldlr Ϫ/Ϫ mice with mice deficient in serum IgM (sIgM Ϫ/Ϫ ) through gene-targeted disruption of the secretory tail of the immunoglobulin chain. 22 Although unable to secrete IgM, sIgM Ϫ/Ϫ B cells maintain membrane IgM expression and have intact class switching and IgG production. 22 We compared sIgM.Ldlr Ϫ/Ϫ mice with C1qa.Ldlr Ϫ/Ϫ mice and with tripledeficient C1qa.sIgM.Ldlr Ϫ/Ϫ mice to contrast the effect of IgM on atherogenesis with selective disruption of the classical pathway.
Methods
Mice sIgM.Ldlr Ϫ/Ϫ mice were generated as described previously 22 and crossed with Ldlr Ϫ/Ϫ mice (both backcrossed 10 times on C57BL/6 background) to generate sIgM.Ldlr Ϫ/Ϫ mice. sIgM.Ldlr Ϫ/Ϫ mice were further crossed with C1qa.Ldlr Ϫ/Ϫ mice 18 to create "triple-knockout" C1qa.sIgM.Ldlr Ϫ/Ϫ mice. From 10 to 22 weeks of age, experimental groups of female mice received either a high-fat (HF) diet or a low-fat (LF) semisynthetic reference diet (see the Methods section in the online-only Data Supplement for details). The following numbers of mice were used for the LF and HF diets, respectively: Ldlr Ϫ/Ϫ , nϭ12 and nϭ12; C1qa.Ldlr Ϫ/Ϫ , nϭ12 and nϭ15; sIgM.Ldlr Ϫ/Ϫ , nϭ14 and nϭ15; and C1qa.sIgM.Ldlr Ϫ/Ϫ , nϭ10 and nϭ9. The aortic root of 1 LF-fed C1qa.sIgM.Ldlr Ϫ/Ϫ mouse was damaged in processing and was not used for analysis. Animal care and procedures were conducted according to institutional guidelines, and mice were kept under specific pathogen-free conditions. Total serum cholesterol and triglycerides were measured with colorimetric enzymatic assays (Infinity, Alpha Labs, Eastleigh, UK). Lipoprotein profiles were generated by fast-performance liquid chromatography on a Superose 6 size-exclusion column.
Atherosclerotic Lesion Analysis
Mice were killed by CO 2 inhalation, and blood was removed from the inferior vena cava. Using a cannula inserted in the left ventricle, we perfused hearts sequentially with Krebs-Henseleit buffer at 37°C for 5 minutes, 2% formalin for 5 minutes, and 2 mL Sudan IV solution by direct slow injection over 5 minutes. Each aorta was microdissected to remove adventitial fat, cut open longitudinally, destained briefly in 80% ethanol, and photographed. En face plaque quantification was performed with ImagePro software (Media Cybernetics, Bethesda, Md) by a single operator blinded to group allocation. Aortic root cryosectioning, Oil Red O staining, and lesion quantification were performed as previously described. 18 
Immunohistochemistry
Aortic root frozen sections were stained by use of standard immunohistochemistry to identify the following cell types: macrophages (MOMA-2 rat monoclonal antibody, Serotec, Kidlington, Oxford, UK), vascular smooth muscle cells (alkaline phosphatase-conjugated anti-␣-smooth muscle actin antibody, Sigma-Aldrich, Poole, UK), and T cells (goat anti-mouse CD3⑀ antibody, Santa Cruz Biotechnology, Santa Cruz, Calif). The presence of lesional deposition of C5b-9 (rabbit anti-human C5b-9 antibody, Calbiochem, Merck Biosciences, Darmstadt, Germany) was identified through the use of the same technique and quantified as percentage lesion area staining positive with ImagePro. Lesional C3 (FITC-conjugated goat anti-mouse C3 antibody, MP Biomedicals, Cambridge, UK) and IgG (FITC-conjugated goat anti-mouse IgG antibody, Sigma-Aldrich) were identified with immunofluorescence and quantified as mean fluorescence intensity per pixel.
Quantification of Lesional Apoptosis
Apoptotic cells were detected with terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL; Roche, Welwyn Garden City, UK) on aortic root cryosections, following the manufacturer's instructions. Randomized slides were quantified by a single operator blinded to group allocation and assessed for number of TUNEL-positive cells fitting morphological criteria for apoptosis, including cell shrinkage, nuclear condensation, or fragmentation, and expressed as percentage of lesional cells.
Confocal Microscopy
For confocal microscopy, 18 aortic root cryosections were double immunostained for CD68 (Alexafluor 488 -conjugated anti-CD68 antibody, Molecular Probes, Invitrogen, Paisley, UK) and IgM (biotin-conjugated mouse anti-mouse IgM b monoclonal antibody and biotin-conjugated mouse anti-mouse IgM a , BD Pharmingen, Oxford, UK) secondarily labeled with Alexa 568 -conjugated streptavidin (Molecular Probes) and counterstained with TOPRO-3.
Lipoprotein Isolation and Modification
Human LDL (density, 1.019 to 1.063 g/mL) was isolated from plasma of healthy donors after an overnight fast by differential density ultracentrifugation 23 and modified with either freshly synthesized MDA or CuSO 4 to generate MDA-LDL and copperoxidized LDL (CuOxLDL) (see the Methods section of the onlineonly Data Supplement). 24
Serum Autoantibody Measurement and Assessment of Autoimmunity
For the detection of anti-MDA-LDL 24 and anti-CuOxLDL antibodies, nonirradiated microtiter plates (Greiner Bio-One, Stonehouse, UK) were coated overnight at 4°C with 15 g/mL MDA-LDL, CuOxLDL, or native LDL in a coating buffer of 100 mmol/L NaHCO 3 and 1 mg/mL Na 2 EDTA or with coating buffer alone to assess nonspecific binding. After washing with PBS with 0.5% Tween-20, plates were blocked with 5% BSA. Sera diluted in PBS-Tween were applied. Alkaline phosphatase-conjugated antimouse IgG, IgM, or IgG 1 antibodies (Southern Biotech, Birmingham, Ala) were used for detection, and plates were developed with p-nitrophenol phosphate. Because Ldlr Ϫ/Ϫ mice on the C57BL/6 background produce IgG 2c (equivalent to IgG 2a b ) antibodies but sIgM.Ldlr Ϫ/Ϫ mice (carrying a 129-derived interval over the Ig gene region) produce IgG 2a (equivalent to IgG 2a a ) (M.B., unpublished data, 2006), to detect IgG 2a and IgG 2c anti-MDA-LDL or anti-CuOxLDL antibodies, we used an alkaline phosphatase-conjugated polyclonal goat anti-mouse IgG 2a (Southern Biotech) with equal specificity for both mouse IgG 2a and IgG 2c over the detection range used (see data in the online-only Data Supplement). Anti-single-stranded DNA, anti-double-stranded DNA, anti-chromatin, and anti-histone antibodies were assayed by ELISA. 25 For anti-cardiolipin and anti-␤ 2 glycoprotein I antibody ELISA assays, and scoring of renal histology for glomerulonephritis, see the Methods section in the online-only Data Supplement.
Statistical Analysis
Results were analyzed with Graphpad Prism version 3.0 (Graphpad Software, San Diego, Calif). When data were not normally distributed, nonparametric statistical tests were used, and results are expressed as median (interquartile range). To compare 2 groups, Mann-Whitney test was used; to compare Ն3 groups, Kruskal-Wallis test followed by Dunn post test was used. Normally distributed data were compared by use of unpaired 2-tailed Student t test, with Bonferroni correction for multiple comparisons. P values were considered significant at PϽ0.05.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results

Localization of IgM in Plaques of Ldlr ؊/؊ Mice
Confocal microscopy was used to examine IgM deposition within atherosclerotic plaques and localization relative to macrophages. IgM was found within lesions in mice on either an LF or HF diet, particularly in the acellular core and with a reciprocal relationship to CD68-positive macrophages ( Figure   1A ). No IgM was detected within atherosclerotic lesions of sIgM.Ldlr Ϫ/Ϫ mice, indicating detection specificity ( Figure 1B ).
Accelerated Atherosclerosis in Serum IgM-Deficient Mice
No significant differences between all 4 mouse strains on either diet were noted in final body weight, total serum cholesterol, triglycerides ( Table I of Figure 2A and 2B). On the HF diet (Figure 2A and 2C 
Increased Lesion Complexity in the Absence of Serum IgM
Aortic root lesions in Ldlr Ϫ/Ϫ mice fed the LF diet were largely fatty streaks, composed virtually entirely of macrophages. On both LF ( Figure 4A ) and HF ( Figure 4B) Figure 4C ). Even on the LF diet, cholesterol crystal deposition was noted in the aortic root lesions of sIgM.Ldlr Ϫ/Ϫ mice ( Figure 4C Ldlr Ϫ/Ϫ mice in the proportion of lesional T lymphocytes (assessed with anti-CD3⑀) on either diet ( Figure 4A and 4B ). Using immunofluorescence for IgG and C3, we quantified mean fluorescent intensity per pixel as an estimate of the density of lesional IgG and C3 deposition. There was no difference in the mean fluorescent intensity for IgG or C3 deposition in aortic root lesions between Ldlr Ϫ/Ϫ and sIgM. Ldlr Ϫ/Ϫ mice on either diet ( Figure 4A through 4C) nor any difference in the level of lesional C5b-9 (not shown).
Clearance of Apoptotic Cell Debris in Atherosclerotic Lesions in the Absence of IgM
Lesional apoptosis in sIgM.Ldlr Ϫ/Ϫ mice was at a level similar to that found in C1qa.Ldlr Ϫ/Ϫ mice, which were previously demonstrated to have impaired lesional apoptotic cell clearance. 18 Figure 5A and 5B). More apoptotic cells were detectable in Ldlr Ϫ/Ϫ controls fed the HF diet; differences between HF-fed groups were not significant ( Figure 5C ).
Autoantibody Production in sIgM.Ldlr ؊/؊ Mice sIgM.Ldlr Ϫ/Ϫ mice on a mixed C57BL/6ϫ129 background have previously been reported to produce anti-doublestranded DNA and anti-cardiolipin antibodies. 26 
Changes in Levels of IgG Antibodies Against MDA-LDL and CuOxLDL
To anti-CuOxLDL antibodies were assayed in Ldlr Ϫ/Ϫ and sIgM. Ldlr Ϫ/Ϫ mice at 22 weeks of age by ELISA. There was a significant increase in IgM and IgG antibodies to CuOxLDL, but not to MDA-LDL, in HF-fed compared with LF-fed Ldlr Ϫ/Ϫ mice, and as expected, IgM antibodies were not detected in sIgM.Ldlr Ϫ/Ϫ sera ( Figure 6 ). There were no significant differences in IgG anti-MDA-LDL or anti-CuOxLDL antibody titer in sIgM.Ldlr Ϫ/Ϫ mice compared with Ldlr Ϫ/Ϫ mice on the LF diet. However, there was a significant reduction in IgG anti-CuOxLDL antibodies in sIgM.Ldlr Ϫ/Ϫ mice fed an HF diet compared with HF-fed Ldlr Ϫ/Ϫ mice. Hypercholesterolemia in ApoE Ϫ/Ϫ mice has been shown to cause a T h 1-to-T h 2 switch, resulting in increased IgG 1 anti-MDA-LDL antibody formation. 24 To investigate whether increased atherosclerosis in sIgM.Ldlr Ϫ/Ϫ mice was associated with an increased T h 2 response, IgG 1 and IgG 2a/2c isotypes also were assayed. For both isotypes, generally no differences were seen between sIgM.Ldlr Ϫ/Ϫ mice, except for slightly lower IgG 2a/2c anti-CuOxLDL antibodies observed in LF-fed sIgM.Ldlr Ϫ/Ϫ mice (significant only at the lowest dilution).
Discussion
Here, we have shown that Ldlr Ϫ/Ϫ mice deficient in serum IgM display a substantial acceleration of atherosclerosis on both an LF and HF diet, with larger lesions, an increase in lesional cholesterol crystal formation, and an increase in vascular smooth muscle cell content consistent with fibrous cap formation. Overall, our data provide the first direct evidence that endogenous IgM natural antibodies are necessary for atheroprotection and build on previous experimental studies on humoral immunity in mice that have shown a reduction in atherosclerosis by (1) B-cell rescue of splenectomized mice, 27 (2) administration of polyclonal human IgG, 28, 29 (3) administration of a monoclonal human IgG 1 antibody against MDA-LDL, 30, 31 and (4) increase in IgM anti-phosphorylcholine antibody levels by vaccination with pneumococci 13 or phosphorylcholine conjugated to keyhole limpet hemocyanin. 14 One of the primary functions of IgM is to activate complement. Previous studies in mouse models have shown increased arterial lipid deposition and macrophage infiltration in mice with C1q or C3 deficiency, suggesting that complement has atheroprotective effects. 18, 32, 33 However, although C1q deficiency was associated with increased vascular smooth muscle cell content in lesions, 18 the opposite was reported in C3-deficient mice, 32 raising the possibility that different modes of complement activation may have distinct effects on atherogenesis. The direct comparison of sIgM. Ldlr Ϫ/Ϫ mice with C1qa.Ldlr Ϫ/Ϫ and triple-knockout C1qa.sIgM.Ldlr Ϫ/Ϫ mice allowed us to gauge how much of the IgM-related atheroprotection was mechanistically linked to downstream classical pathway complement activation via C1q. As previously published, C1qa.Ldlr Ϫ/Ϫ mice on the LF diet showed a modest increase in aortic root lesion size, but C1q deficiency had no detectable effect in mice fed an HF diet. 18 The differences here between sIgM.Ldlr Ϫ/Ϫ and C1qa.Ldlr Ϫ/Ϫ mice demonstrate a hierarchy, with IgM playing a dominant role. Consistent with this, the combined deficiency of C1q and sIgM showed no difference in the level of atherosclerosis compared with IgM deficiency alone. It is possible that in the absence of C1q, IgM may bypass the classical pathway and instead activate the lectin pathway, 34 as has been shown in ischemia/reperfusion injury. 35 However, in the sIgM.Ldlr Ϫ/Ϫ mice, we found no difference in the density of lesional C3 or C5b-9 staining compared with the Ldlr Ϫ/Ϫ mice, suggesting that at least part of the mechanism by which IgM exerts its protective effect in atherosclerosis is independent of complement activation in the arterial wall.
Both C1q and IgM have been implicated as important recognition molecules mediating the clearance of dying cells. 17, 36 We observed increased levels of apoptotic cells and TUNEL-positive cellular debris within aortic root atherosclerotic plaques of sIgM.Ldlr Ϫ/Ϫ mice, similar to those seen in C1qa.Ldlr Ϫ/Ϫ mice. 18 Increased lesional apoptosis was not observed in C1qa.sIgM.Ldlr Ϫ/Ϫ mice, raising the possibility of compensatory mechanisms occurring within the tripleknockout mice. There was no difference in apoptotic cell numbers between the groups on the HF diet, primarily because of increased lesional apoptosis in Ldlr Ϫ/Ϫ controls. It is important to note that although defective clearance of cellular debris within atherosclerotic plaques may be a significant contributing factor to the increase in lesion size noted in sIgM.Ldlr Ϫ/Ϫ and C1qa.Ldlr Ϫ/Ϫ mice on the LF diet, increased numbers of lesional apoptotic cells also may be a function of lesion size. Overall, the data on lesional apoptotic cells do not support a failure of apoptotic cell clearance as being the only or even the major mechanism by which IgM deficiency accelerates atherosclerosis and certainly do not account for the greater lesion size in sIgM.Ldlr Ϫ/Ϫ compared with C1qa.Ldlr Ϫ/Ϫ mice.
Although deficiency of serum IgM has been shown to predispose to the development of anti-double-stranded DNA and anti-cardiolipin antibodies on certain murine genetic backgrounds, 26, 37 sIgM.Ldlr Ϫ/Ϫ mice do not develop autoantibodies when fully backcrossed onto the C57BL/6 background (M. Botto, unpublished). Unexpectedly, we observed that sIgM.Ldlr Ϫ/Ϫ mice on the HF diet developed anti-singlestranded DNA autoantibodies, supporting previous observations that there is an interaction between hypercholesterolemia and predisposition to lupus-like autoimmunity. 19 Hence, IgM deficiency enhances autoimmunity in both a straindependent and lipid-dependent manner. It should be noted, however, that the levels of anti-single-stranded DNA in sIgM.Ldlr Ϫ/Ϫ mice on the HF diet were low compared with those seen in classical lupus models (eg, MRL/lpr), and no mice developed renal disease. It therefore seems unlikely that lupus-like autoimmunity contributed significantly to the accelerated arterial disease we observed.
The main purpose of measuring levels of IgG antibodies against MDA-LDL and CuOxLDL was to check whether removal of IgM would result in a change in predominant IgG isotype or a compensatory increase in levels of IgG antibodies to these antigens. There was no evidence in sIgM.Ldlr Ϫ/Ϫ mice of a change in IgG isotype reflecting a T h 1-to-T h 2 switch. 24 Paradoxically, there was a significant reduction in IgG antibodies against CuOxLDL in sIgM.Ldlr Ϫ/Ϫ mice fed an HF diet compared with Ldlr Ϫ/Ϫ mice. Although theoretically this may be due to an idiosyncratic reduction in IgG synthesis related to IgM deficiency, class switching is thought to be relatively normal in sIgM.Ldlr Ϫ/Ϫ mice. 22 One plausible explanation is that the lower IgG CuOxLDL antibody level in HF-fed sIgM.Ldlr Ϫ/Ϫ mice is due to depletion of IgG by oxLDL particles that would have bound IgM in Ldlr Ϫ/Ϫ mice. This raises the question as to what extent the protective effect of IgM is related to actions such as inhibition of uptake of oxLDL by macrophages within lesions 7 and how much is due to facilitating safe clearance of oxLDL from the circulation or other tissues. For example, IgM may well be important for opsonizing circulating oxLDL particles and targeting them to the liver, which is known to be the major organ for circulating oxLDL uptake. 38 Although mechanistic conclusions cannot be drawn from clinical studies relating antibody levels with disease, it is relevant that there have been reports showing inverse correlations between serum levels of IgM anti-oxLDL or antiphosphorylcholine antibodies and progression of carotid atherosclerosis, 39 -41 as well as angiographically determined coronary artery disease. 42 Taken together with the emerging experimental evidence in this and previous studies that IgM and IgG antibodies can be atheroprotective, there is increasing rationale for therapeutic strategies aimed at boosting humoral immunity. Conversely, B-cell depletion therapy with the anti-CD20 monoclonal antibody rituximab is increasingly used to treat autoimmune conditions, including systemic lupus erythematosus and rheumatoid arthritis. Up to 20% of patients with rheumatoid arthritis treated with repeated courses of B-cell depletion develop abnormally low levels of sIgM, with less effect on serum IgG levels. 43 vascular risk as a result of preferential depletion of serum IgM in a population already susceptible to cardiovascular complications. 44 
